Based in Bloomington, Minnesota, ICT is one of the world's leading suppliers of unique in vivo and in vitro tools critical for discovering promising investigational medicines for treating life threatening illnesses.
Our fluorescent enzyme detection probes are used to assess apoptosis and cell death in cultured cells. ICT's specialty in vitro probes detect caspases, cathepsins, serine proteases, cholinesterase enzymes, and assess mitochondrial health. We also manufacture proprietary probes that can detect dead and dying cells in living organisms in vivo for research use. In the future, these probes may be used to better manage disease and personalize treatment. ICT's in vivo probes may be used to assess the efficacy of chemotherapy, to quantify neurodegeneration, and as an early detector of eye disease, among other applications.
ICT is also a contract research laboratory specializing in custom ELISA development, manufacturing, and testing services. As an out-growth of these services, ICT offers a specialty line of ELISA buffers and stabilizers to researchers developing in-house assays.
